Level 1 — Absolute Beginner

A company called Verily, which is part of Alphabet (the owner of Google), wants to release millions of mosquitoes into the wild. This sounds surprising, but these special mosquitoes are meant to reduce the number of harmful mosquitoes.

These mosquitoes are male. Male mosquitoes do not bite people. They carry tiny bacteria that make wild female mosquitoes lay eggs that cannot hatch. Over time, the mosquito population gets smaller.

The goal is to fight West Nile virus, a disease spread by certain mosquitoes. West Nile virus can make people very sick. Reducing the number of mosquitoes helps protect people from this illness.

A test in the city of Fresno showed that this method worked very well. The number of these mosquitoes went down by more than 90 percent in the test area. Verily asked the US government for permission to try it in more places.

mosquito

a small flying insect that feeds on blood; some types spread diseases

bacteria

tiny living organisms, some of which can affect the health of plants, animals, and humans

hatch

to come out of an egg and begin life

population

the total number of a particular animal or type of organism in an area

disease

an illness caused by bacteria, viruses, or other harmful things

permission

official approval from an authority to do something

release

to set free or let go into the environment

reduce

to make something smaller in number or amount

Level 2 — Elementary

Alphabet's life sciences unit Verily applied to the US Environmental Protection Agency (EPA) for a permit to release up to 32 million male Culex quinquefasciatus mosquitoes across California and Florida over two years. This is part of Verily's Debug program. The public comment period closed on June 5, 2026.

The mosquitoes are infected with a naturally occurring bacterium called Wolbachia. When a Wolbachia-carrying male mates with a wild female that does not have the same type of Wolbachia, the resulting eggs are unable to develop. This process is called cytoplasmic incompatibility, and it causes the local mosquito population to decline.

The Culex quinquefasciatus species is the main carrier of West Nile virus and St. Louis encephalitis virus in the United States. Both diseases can cause serious brain inflammation in humans. Reducing its population in target areas could lower the number of human infections.

Verily uses AI-driven sorting machines to separate male mosquitoes from females with more than 99 percent accuracy, releasing only males at a rate exceeding one million per day. A pilot study in Fresno, California achieved more than 90 percent suppression of the target mosquito population in treated zones. No genetically modified organisms are used in the program.

Wolbachia

a naturally occurring bacterium found in many insects, sometimes used in pest control programs

cytoplasmic incompatibility

a biological mismatch caused by Wolbachia that prevents mosquito eggs from developing after mating

Culex quinquefasciatus

a species of mosquito common in the southern United States that is the main carrier of West Nile virus

encephalitis

inflammation of the brain, often caused by a viral infection

suppression

the act of reducing or eliminating something, such as a pest population

permit

official written permission from a government authority to carry out a specific activity

genetically modified organism

a plant or animal whose DNA has been changed in a laboratory to give it new characteristics

pilot study

a small-scale test of a method or program before a larger rollout

Level 3 — Intermediate

Verily Life Sciences, Alphabet's biomedical research unit, submitted an application to the EPA for an Experimental Use Permit (EUP) to deploy up to 32 million Wolbachia-infected male Culex quinquefasciatus mosquitoes across targeted areas in California and Florida over a 24-month trial under its Debug program. The EPA's public comment period for the application closed on June 5, 2026. The EUP category is used for biological pest control methods that require real-world data collection before a full commercial registration can be approved.

The mechanism relies on cytoplasmic incompatibility (CI). Wolbachia is a genus of intracellular bacteria present in up to 60 percent of arthropod species globally. When Wolbachia-carrying males mate with wild females lacking the compatible Wolbachia strain, fertilised eggs arrest in development and fail to hatch. Crucially, no genetic modification of the mosquitoes' own DNA occurs. The released males carry a naturally occurring bacterial passenger, making the approach distinct from transgenic sterile insect technique programs.

Verily's AI-driven sex-sorting pipeline processes over one million mosquitoes per day with greater than 99 percent male purity. This precision is necessary because even a small proportion of Wolbachia-carrying females released into the environment could potentially establish the bacterium in wild populations, disrupting the incompatibility effect. In the Fresno pilot, covering approximately 300 acres in the Central Valley, weekly releases over two seasons achieved more than 90 percent suppression of Culex quinquefasciatus. Researchers noted that a density-dependent compensation effect, in which the surviving population breeds more rapidly, limited the absolute elimination of the species.

West Nile virus remains the most prevalent mosquito-borne neurological disease in the United States. The CDC reported over 2,500 cases in 2025, with roughly 30 percent involving neuroinvasive disease causing encephalitis or meningitis. California and Florida account for a disproportionate share of cases due to climate, resident bird populations that serve as reservoirs, and high densities of Culex quinquefasciatus. The EUP application represents the largest proposed deployment of the Wolbachia CI technique in the continental United States to date.

Experimental Use Permit

an EPA authorisation allowing limited field testing of a new pesticide or biological control agent while safety and efficacy data are collected

intracellular bacteria

bacteria that live and reproduce inside the cells of a host organism rather than independently

transgenic

describing an organism whose DNA has been modified by inserting genes from another species

sterile insect technique

a pest control method in which large numbers of sterile males are released to mate with wild females, producing no offspring

sex-sorting pipeline

Level 4 — Advanced

Verily Life Sciences' EPA Experimental Use Permit application for the Debug program's Culex quinquefasciatus suppression initiative represents a significant regulatory test for Wolbachia-based cytoplasmic incompatibility (CI) as a scalable vector control tool in the continental United States. The program is conceptually distinct from transgenic sterile insect technique (SIT) approaches, such as Oxitec's OX513A Aedes aegypti strain, because it introduces no exogenous DNA into the target species. Instead, it harnesses a naturally occurring endosymbiont, Wolbachia pipientis, which induces sperm-egg incompatibility when CI-Wolbachia-carrying males mate with incompatible wild females, causing embryonic arrest in fertilised eggs.

The central regulatory and ecological debate concerns reversibility and population-level off-target effects. Wolbachia CI programs are self-limiting in theory: without continuous mass releases, CI males are diluted by wild males and the effect dissipates. However, if any Wolbachia-carrying females escape the sex-sorting pipeline, the bacterium's fitness advantages, including protection from RNA viruses and increased reproductive rate under some conditions, could enable it to spread through the wild Culex population. Horizontal transfer of Wolbachia between arthropod species via shared host plants or parasitoid intermediaries, while uncommon, has been documented and represents a non-trivial biosafety consideration.

Verily's AI-driven sex-sorting platform, which achieves greater than 99 percent male purity at throughputs exceeding one million individuals per day, is the operational linchpin of the program. The pipeline combines multi-spectral optical sensing, machine-learning classification trained on morphological features, and high-speed pneumatic sorting. At the proposed deployment scale of 32 million individuals over 24 months, the logistical footprint, including insectary capacity, cold-chain distribution to field release sites, and weekly release scheduling, represents a manufacturing and supply-chain challenge with no precedent in US vector control history.

From a public health calculus perspective, the case for the EUP is strong. West Nile virus neuroinvasive disease imposes substantial morbidity and mortality, with a case-fatality rate of approximately 10 percent in neuroinvasive cases and a high rate of long-term neurological sequelae among survivors. Conventional vector control, which relies on synthetic pyrethroid and organophosphate larvicides and adulticides, faces growing insecticide resistance in Culex quinquefasciatus populations and generates non-target arthropod mortality. Wolbachia CI offers a species-selective, insecticide-free alternative. The EUP outcome will set a precedent for the regulatory treatment of non-transgenic biological vector control at city and county scale.

endosymbiont

an organism that lives inside the cells or body of another organism in a mutually close relationship, not always beneficial to the host